相关实验视频
Updated: Jan 14, 2026
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
68.8K
诊断炎症性肠病 (IBD) 的临床实践指南:一个范围审查
Chelsea Doyle1, Charlotte Combes1, Meri Lioulios1
1UniSA Allied Health & Human Performance University of South Australia South Australia Australia.
Health science reports
|October 17, 2025
概括
炎症性肠病 (IBD) 诊断的临床实践指南在全球范围内显示出显著的差异. 协调诊断标准和改进指导方针的制定对于在这种慢性自身免疫性疾病中提供一致的患者护理至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 临床实践指南 临床实践指南
- 自身免疫性疾病 自身免疫性疾病
背景情况:
- 炎症性肠病 (IBD) 是一种具有诊断不一致性的慢性自身免疫性疾病.
- 目前用于IBD诊断的临床实践指南 (CPG) 在全球范围内存在差异.
- 本次审查解决了改善IBD诊断一致性的需要.
研究的目的:
- 评估目前的全球临床实践指南 (CPG) 对于炎症性肠病 (IBD) 诊断.
- 在不同的指南中识别和分类诊断建议.
- 评估IBD诊断指南的方法质量和适用性.
主要方法:
- 使用PRISMA-Scr方法进行了范围审查.
- 通过广泛的数据库和灰色文献搜索,通过广泛的数据库和灰色文献搜索确定了在过去5年内出版的11个CPG.
- 使用AGREE-II工具进行数据提取和批判性评估,由两名独立审查员进行.
主要成果:
- 11个CPG提供了21个IBD的诊断建议.
- 建议涵盖了病史,体检,血液检查,CT,超声波,内镜,结肠镜和MRI.
- 在指南中观察到诊断建议的显著差异和不一致的方法质量.
结论:
- 对IBD的诊断建议因区域实践和不同的方法严格性而在CPG中存在差异.
- 不一致的方法质量,特别是适用性,需要在指导方针开发中进行改进.
- 显然需要协调诊断标准,加强指导方针的制定,以及进一步的研究,以解决IBD诊断中的实施差距.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
635
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
635
01:30Inflammatory Bowel Disease II: Crohn's Disease
947
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
947
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
891
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
891
01:29Inflammatory Bowel Disease IV: Pharmacological Management
496
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
496
01:17Chronic Bowel Disorders: Introduction
744
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
744
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
727
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
727